Prednisone Treatment for Vestibular Neuronitis (NCT00271791) | Clinical Trial Compass
CompletedPhase 2
Prednisone Treatment for Vestibular Neuronitis
Israel17 participantsStarted 2005-09
Plain-language summary
The purpose of the study is to investigate the value of steroids in the treatment of vestibular neuronitis. The potential benefits of steroid therapy would be analyzed by the clinical response, self-perceived handicap and laboratory parameters.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Clinical diagnosis of vestibular neuronitis.
* Documentation of unilateral reduced caloric response (caloric asymmetry \>25%) on the EOG caloric study.
Exclusion Criteria:
* Complaints of new hearing loss, tinnitus, or neurological deficits.
* The presence of previously non-diagnosed sensorineural hearing loss (SNHL)
* History of vestibular dysfunction.
* Patient younger than 18 years of age.
* Known contra-indication to systemic steroids: Unbalanced hypertension, un-controlled diabetes mellitus, immunodeficiency, active peptic disease, and avascular necrosis of the femoral head.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial tested prednisone — a steroid — for vestibular neuronitis, and it's already completed; can you tell me what the results showed and whether prednisone is now considered a standard or recommended treatment for my condition?
2The trial measured things like nystagmus and disequilibrium on bedside examination — are those the same symptoms I'm experiencing, and how do my specific exam findings compare to what was being tracked in this study?
3Since this was a Phase 2 trial, what does that mean for how confident we can be about prednisone's safety and effectiveness for vestibular neuronitis, and is there stronger evidence from later studies I should know about?
4Are there other treatment options for vestibular neuronitis — like vestibular rehabilitation exercises or antiviral medications — that I should consider alongside or instead of what this trial was testing?
5Given that this trial is now completed, is prednisone something you'd actually prescribe for me based on what this and other research has found, or are there reasons my situation might make it less appropriate?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Clinical: The presence of static and dynamic nystagmus, positional and positioning nystagmus, and disequilibrium on bedside examination.